Nearly 17M U.S. Teens, Young Adults Eligible for GLP-1 Agonists

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(Medage today) – Although about 17 million American and young adults are eligible for agonists of GLP -1 receptors for conditions such as obesity and type 2 diabetes, many were lacking in insurance or a routine place for health care, a transversal section …

:max_bytes(150000):strip_icc()/GettyImages-1187671319-e4b3c37bb83e489996b02741be450c38.jpg?w=390&resize=390,220&ssl=1)


